NASDAQ Global Market • Healthcare • Biotechnology • US • USD
The analyst consensus price target for TRAW is $8.00, representing a +550.4% upside from the current price of $1.23. Price targets range from a low of $8.00 to a high of $8.00.
No analyst consensus data available for TRAW.
Be the first to know when stocks drop below their intrinsic value.
